Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
Status:
Recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
To see the impact of obesity on the efficacy of adjuvant endocrine therapy with aromatase
inhibitors in postmenopausal patients with early breast cancer in terms of:
i) Locoregional recurrence ii) Distant metastases iii) Disease-free survival iv) Overall
survival
Phase:
Phase 3
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research